Company profile

Confo Therapeutics

Exploiting the conformational complexity of GPCRs to innovate drug discovery

Industry
Biotechnology
Employees
81
Headquarters
Zwijnaarde
Founded
2015
Office locations
1

Confo Therapeutics company summary

Confo Therapeutics is a company in the Biotechnology industry, headquartered in Zwijnaarde, founded in 2015. On LinkedIn the company has around 81 employees. Its listed specialties include Drug discovery, Antibody technology, G protein coupled receptors, Drug development.

What technology does Confo Therapeutics use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Confo Therapeutics

Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets. This technology platform combined with the pharmacologic and biologic insight it provides, allows Confo to build a multi-indication pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying treatments. Confo Therapeutics was spun out of Vrije Universiteit Brussel (VUB) and VIB in 2015. Supported by international life-science focused investors and led by an experienced team of entrepreneurial professionals and scientists from successful biopharmaceutical companies, Confo Therapeutics benefits from the rich scientific and innovative ecosystem in Belgium. For more information: www.confotherapeutics.com

Specialties

Drug discoveryAntibody technologyG protein coupled receptorsDrug development

Where is Confo Therapeutics located?

Confo Therapeutics lists 1 location.

Zwijnaarde, 9052, BEHQ
Technologiepark-Zwijnaarde 30

Compare companies similar to Confo Therapeutics

More companies in Biotechnology.

CompanyIndustryEmployeesFoundedHeadquarters
Confo Therapeutics
confotherapeutics.com
Biotechnology812015Zwijnaarde
Regeneron
regeneron.com
Biotechnology17,234-Tarrytown, New York
Bharat Biotech
bharatbiotech.com
Biotechnology2,0351996Hyderabad, Telangana
Biotechnology1,0232008Pune, Maharashtra
Biotechnology393-Bethesda, MD
Biotechnology2,6502004Chennai, India
Biotechnology6922001Cambé, PR
Organica Biotech
organicabiotech.com
Biotechnology1462000Mumbai, Maharashtra
Biotechnology2172017South San Francisco, California
Biotechnology2271971Lagoa Santa, Minas Gerais
Biotechnology2432015London, United Kingdom

Frequently asked questions about Confo Therapeutics

What does Confo Therapeutics do?

Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets. This technology platform combined with the pharmacologic and biologic insight it provides, allows Confo to build a multi-indication pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying treatments. Confo Therapeutics was spun out of Vrije Universiteit Brussel (VUB) and VIB in 2015. Supported by international life-science focused investors and led by an experienced team of entrepreneurial professionals and scientists from successful biopharmaceutical companies, Confo Therapeutics benefits from the rich scientific and innovative ecosystem in Belgium. For more information: www.confotherapeutics.com

How many employees does Confo Therapeutics have?

Confo Therapeutics has around 81 employees on LinkedIn.

Where is Confo Therapeutics headquartered?

Confo Therapeutics is headquartered in Zwijnaarde.

When was Confo Therapeutics founded?

Confo Therapeutics was founded in 2015.

Build a lead list from companies like Confo Therapeutics

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.